世界のタンパク質工学市場:技術別(合理的設計、不合理な設計)、製品&サービス別(機器、消耗品)、タンパク質種類別(モノクローナル抗体、インスリン)、エンドユーザー別(アカデミックインスティテュート、バイオ医薬品、CRO)

【英語タイトル】Protein Engineering Market by Technology (Rational Design, Irrational Design), Product & Service (Instrument, Consumables), Protein Type (Monoclonal Antibodies, Insulin), End User (Academics Institutes, Biopharmaceuticals, CROs) - Global Forecast to 2024

MarketsandMarketsが出版した調査資料(BT 7517)・商品コード:BT 7517
・発行会社(調査会社):MarketsandMarkets
・発行日:2020年1月30日
・ページ数:147
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
MarketsandMarkets社は、タンパク質工学の世界市場規模が2019年22億ドルから2024年39億ドルまで年平均12.4%成長すると予測しています。本調査レポートでは、世界のタンパク質工学市場を広く調査・分析し、市場概要、製品&サービス別(計器、消耗品、ソフトウェアおよびサービス)分析、タンパク質種類別(モノクローナル抗体、インスリン、エリスロポエチン、インターフェロン、ワクチン、コロニー刺激因子、成長ホルモン、凝固因子、その他のタンパク質)分析、技術別(合理的なタンパク質設計、不合理なタンパク質設計/指向進化)分析、エンドユーザー別(バイオ医薬品会社、受託研究機関、学術研究機関)分析、地域別分析、競合動向、企業概要などで取りまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のタンパク質工学市場:製品&サービス別(計器、消耗品、ソフトウェアおよびサービス)
・世界のタンパク質工学市場:タンパク質種類別(モノクローナル抗体、インスリン、エリスロポエチン、インターフェロン、ワクチン、コロニー刺激因子、成長ホルモン、凝固因子、その他のタンパク質)
・世界のタンパク質工学市場:技術別(合理的なタンパク質設計、不合理なタンパク質設計/指向進化)
・世界のタンパク質工学市場:エンドユーザー別(バイオ医薬品会社、受託研究機関、学術研究機関)
・世界のタンパク質工学市場:地域別
・競合動向
・企業概要

【レポートの概要】

“The increasing focus on protein-based drug development by pharmaceutical and biotechnology firms is expected to drive the overall growth of the protein engineering market”
The global protein engineering market is estimated to grow from USD 2.2 billion in 2019 to USD 3.9 billion by 2024, at a CAGR of 12.4% during the forecast period. The major factors driving the growth of this market include the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies.

“Instruments segment to account for the largest share of the protein engineering market, by product & service, in 2019”
Based on product & service, the protein engineering market is segmented into instruments, consumables, and software & services. Instruments formed the largest product segment in this market in 2019 due to technological advancements in mass spectrometry and X-ray crystallography systems and their ability to integrate with other technologies.

“Monoclonal antibodies segment to grow at the highest CAGR in the protein engineering market, by protein type, in 2019”
Based on protein type, the protein engineering market is segmented into monoclonal antibodies, insulin, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins. The monoclonal antibodies segment is estimated to grow at the highest CAGR in this market owing to the increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.

“Rational protein design segment to grow at the highest CAGR in the protein engineering market, by technology, in 2019”
Based on technology, the protein engineering market is segmented into rational and irrational protein design. The rational protein design segment is estimated to grow at the highest CAGR in this market during the forecast period majorly due to the growing use and continuous upgrades of bioinformatics platforms and software for protein analysis.

“North America is estimated to be the largest regional market for protein engineering products and services during the forecast period”
In 2019, North America accounted for the largest share of the global protein engineering market, majorly due to the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research in the region. Also, the increased adoption of biologic drugs such as monoclonal antibodies, erythropoietin, and interferons for the treatment of chronic diseases is the major factor driving the growth of the North American market.

In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the protein engineering market. Mentioned below is the breakdown of the interviews:
• By Respondent Type: Supply Side: 80%, Demand Side: 20%
• By Designation: C-level Executives: 25%, Directors: 18%, Others: 57%
• By Region: North America: 50%, Europe: 20%, APAC: 20%, RoW: 10%
The major players operating in the global protein engineering market include Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), and Danaher Corporation (US).

Research Coverage:
The study covers the protein engineering market across various segments. It aims at estimating the market size and the growth potential of this market across different product & service, protein type, technology, end user, and regional segments. The study also includes an in-depth competitive analysis of the key players operating in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
This report will help market leaders as well as new entrants in the market by providing information on the closest approximations of the revenue numbers for the overall protein engineering market and its subsegments. It will also help stakeholders to understand the competitive landscape, gain more insights to better position their businesses, and plan suitable go-to-market strategies.

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Covered
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Data Triangulation
2.3.1 Assumptions for the Study
2.3.2 Limitations
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 31)
4.1 Market Overview
4.2 Asia Pacific: Market, By Product (2018)
4.3 Market, By End User (2018)
4.4 Market, By Region (2018)
5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Investments in Synthetic Biology
5.2.1.2 Growing Focus on Protein-Based Drug Development By Pharmaceutical & Biotechnology Firms
5.2.2 Restraints
5.2.2.1 High Cost of Instruments
5.2.3 Opportunities
5.2.3.1 Emerging Markets
6 Protein Engineering Market, By Product & Service (Page No. – 37)
6.1 Introduction
6.2 Instruments
6.2.1 Instruments Will Continue to Dominate the Market in the Forecast Period
6.3 Consumables
6.3.1 Increasing Demand for Consumables in Proteomics Research is Supporting Market Growth
6.4 Software & Services
6.4.1 Software & Services Segment to Witness the Highest Growth Between 2019 and 2024
7 Protein Engineering Market, By Protein Type (Page No. – 43)
7.1 Introduction
7.2 Monoclonal Antibodies
7.2.1 Accurate Binding Capacity and Specificity Have Supported the use of MABs
7.3 Insulin
7.3.1 Increasing Burden of Diabetes has Driven the Demand for Insulin
7.4 Erythropoietins
7.4.1 Continuous Research and Funding to Promote the Growth of Erythropoietins
7.5 Interferons
7.5.1 Rising Anemia Incidence is a Key Driver of the Market for Interferons
7.6 Vaccines
7.6.1 High Incidence of Diseases Such as Hepatitis and Influenza Likely to Boost Market Growth
7.7 Colony-Stimulating Factors
7.7.1 Demand for CSF in Bone and Inflammation Treatment Likely to Boost the Market
7.8 Growth Hormones
7.8.1 Demand for Hormone Therapies Likely to Boost the Market
7.9 Coagulation Factors
7.9.1 The Need to Combat Hemophilia is Expected to be the Primary Growth Driver for This Market Segment
7.10 Other Proteins
8 Protein Engineering Market, By Technology (Page No. – 58)
8.1 Introduction
8.2 Rational Protein Design
8.2.1 Advancements in Bioinformatics Tools to Propel Market Growth
8.3 Irrational Protein Design/Directed Evolution
8.3.1 This Process Involves a Number of Uncertainties, Which May Limit Market Growth to a Certain Extent
9 Protein Engineering Market, By End User (Page No. – 63)
9.1 Introduction
9.2 Biopharmaceutical Companies
9.2.1 Biopharmaceutical Companies Dominate the Market
9.3 Contract Research Organizations
9.3.1 Increasing Need for Outsourcing Protein Engineering Activities to Cros to Support Market Growth
9.4 Academic Research Institutes
9.4.1 Need for Novel Proteins for the Production of Biotherapeutics to Boost Market Growth
10 Protein Engineering Market, By Region (Page No. – 70)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Patent Expiry and Increasing Research Funds
10.2.2 Canada
10.2.2.1 R&D Activities in Research Institutes and Universities to Drive Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Strong R&D Base and Presence of Research Centers to Drive Market Growth
10.3.2 UK
10.3.2.1 Strong Preclinical Pipeline to Support Market Growth
10.3.3 France
10.3.3.1 Conference and Events in France Likely to Create Awareness
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Government Initiatives in Genomics and Proteomics are Likely to Support Market Growth in Japan
10.4.2 China
10.4.2.1 Presence of a Favorable Funding Scenario and Collaborations Will Drive Market Growth
10.4.3 India
10.4.3.1 Government Initiatives Will Propel Market Growth in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape (Page No. – 97)
11.1 Introduction
11.2 Market Rank Analysis, 2018
11.3 Competitive Leadership Mapping (2019)
11.3.1 Vendor Inclusion Criteria
11.3.2 Visionary Leaders
11.3.3 Innovators
11.3.4 Dynamic Differentiators
11.3.5 Emerging Companies
11.4 Competitive Scenario
11.4.1 Partnerships, Agreements, and Collaborations (2016–2019)
11.4.2 Product Launches & Enhancements (2016–2019)
11.4.3 Expansions (2016–2019)
11.4.4 Acquisitions (2016–2019)
12 Company Profiles (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Thermo Fisher Scientific, Inc.
12.2 Danaher Corporation
12.3 Agilent Technologies, Inc.
12.4 Bio-Rad Laboratories, Inc.
12.5 Bruker Corporation
12.6 Genscript Biotech Corporation
12.7 Codexis, Inc.
12.8 Waters Corporation
12.9 New England Biolabs, Inc.
12.10 Merck KGaA
12.11 Perkinelmer, Inc.
12.12 GE Healthcare
12.13 Creative Biolabs
12.14 Enantis S.R.O.
12.15 Promega Corporation
12.16 Abzena, Ltd.
12.17 Proteogenix
12.18 Innovagen AB
12.19 Phynexus, Inc. (A Part of Biotage)
12.20 Takara Bio, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 140)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (132 Tables)
Table 1 Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 2 Protein Engineering Instruments Market, By Region, 2017–2024 (USD Million)
Table 3 North America: Protein Engineering Instruments Market, By Country, 2017–2024 (USD Million)
Table 4 Europe: Protein Engineering Instruments Market, By Country, 2017–2024 (USD Million)
Table 5 APAC: Protein Engineering Instruments Market, By Country, 2017–2024 (USD Million)
Table 6 Protein Engineering Consumables Market, By Region, 2017–2024 (USD Million)
Table 7 North America: Protein Engineering Consumables Market, By Country, 2017–2024 (USD Million)
Table 8 Europe: Protein Engineering Consumables Market, By Country, 2017–2024 (USD Million)
Table 9 APAC: Protein Engineering Consumables Market, By Country, 2017–2024 (USD Million)
Table 10 Protein Engineering Software & Services Market, By Region, 2017–2024 (USD Million)
Table 11 North America: Protein Engineering Software & Services Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: Protein Engineering Software & Services Market, By Country, 2017–2024 (USD Million)
Table 13 APAC: Protein Engineering Software & Services Market, By Country, 2017–2024 (USD Million)
Table 14 Protein Engineering Market, By Protein Type, 2017–2024 (USD Million)
Table 15 Market for Monoclonal Antibodies, By Region, 2017–2024 (USD Million)
Table 16 North America: Market for Monoclonal Antibodies, By Country, 2017–2024 (USD Million)
Table 17 Europe: Market for Monoclonal Antibodies, By Country, 2017–2024 (USD Million)
Table 18 APAC: Market for Monoclonal Antibodies, By Country, 2017–2024 (USD Million)
Table 19 Market for Insulin, By Region, 2017–2024 (USD Million)
Table 20 North America: gineering Market for Insulin, By Country, 2017–2024 (USD Million)
Table 21 Europe: Market for Insulin, By Country, 2017–2024 (USD Million)
Table 22 APAC: Market for Insulin, By Country, 2017–2024 (USD Million)
Table 23 Market for ErythropOIEtins, By Region, 2017–2024 (USD Million)
Table 24 North America: Market for ErythropOIEtins, By Country, 2017–2024 (USD Million)
Table 25 Europe: Protein Engineering Market for ErythropOIEtins, By Country, 2017–2024 (USD Million)
Table 26 APAC: Market for ErythropOIEtins, By Country, 2017–2024 (USD Million)
Table 27 Market for Interferons, By Region, 2017–2024 (USD Million)
Table 28 North America: Market for Interferons, By Country, 2017–2024 (USD Million)
Table 29 Europe: Market for Interferons, By Country, 2017–2024 (USD Million)
Table 30 APAC: Market for Interferons, By Country, 2017–2024 (USD Million)
Table 31 Market for Vaccines, By Region, 2017–2024 (USD Million)
Table 32 North America: Market for Vaccines, By Country, 2017–2024 (USD Million)
Table 33 Europe: Market for Vaccines By Country, 2017–2024 (USD Million)
Table 34 APAC: Market for Vaccines, By Country, 2017–2024 (USD Million)
Table 35 Market for Colony-Stimulating Factors, By Region, 2017–2024 (USD Million)
Table 36 North America: Market for Colony-Stimulating Factors, By Country, 2017–2024 (USD Million)
Table 37 Europe: Market for Colony-Stimulating Factors, By Country, 2017–2024 (USD Million)
Table 38 APAC: Market for Colony-Stimulating Factors, By Country, 2017–2024 (USD Million)
Table 39 Market for Growth Hormones, By Region, 2017–2024 (USD Million)
Table 40 North America: Protein Engineering Market for Growth Hormones, By Country, 2017–2024 (USD Million)
Table 41 Europe: Market for Growth Hormones, By Country, 2017–2024 (USD Million)
Table 42 APAC: Market for Growth Hormones, By Country, 2017–2024 (USD Million)
Table 43 Market for Coagulation Factors, By Region, 2017–2024 (USD Million)
Table 44 North America: Market for Coagulation Factors, By Country, 2017–2024 (USD Million)
Table 45 Europe: Market for Coagulation Factors, By Country, 2017–2024 (USD Million)
Table 46 APAC: Market for Coagulation Factors, By Country, 2017–2024 (USD Million)
Table 47 Market for Other Proteins, By Region, 2017–2024 (USD Million)
Table 48 North America: Market for Other Proteins, By Country, 2017–2024 (USD Million)
Table 49 Europe: Protein Engineering Market for Other Proteins, By Country, 2017–2024 (USD Million)
Table 50 APAC: Market for Other Proteins, By Country, 2017–2024 (USD Million)
Table 51 Market, By Technology, 2017–2024 (USD Million)
Table 52 Market for Rational Protein Design, By Region, 2017–2024 (USD Million)
Table 53 North America: Market for Rational Protein Design, By Country, 2017–2024 (USD Million)
Table 54 Europe: Market for Rational Protein Design, By Country, 2017–2024 (USD Million)
Table 55 APAC: Protein Engineering Market for Rational Protein Design, By Country, 2017–2024 (USD Million)
Table 56 Market for Irrational Protein Design, By Region, 2017–2024 (USD Million)
Table 57 North America: Market for Irrational Protein Design, By Country, 2017–2024 (USD Million)
Table 58 Europe: Market for Irrational Protein Design, By Country, 2017–2024 (USD Million)
Table 59 APAC: Market for Irrational Protein Design, By Country, 2017–2024 (USD Million)
Table 60 Market, By End User, 2017–2024 (USD Million)
Table 61 Market for Biopharmaceutical Companies, By Region, 2017–2024 (USD Million)
Table 62 North America: Market for Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 63 Europe: Market for Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 64 APAC: Market for Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 65 Market for Contract Research Organizations, By Region, 2017–2024 (USD Million)
Table 66 North America: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 67 Europe: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 68 APAC: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 69 Market for Academic Research Institutes, By Region, 2017–2024 (USD Million)
Table 70 North America: Market for Academic Research Institutes, By Country, 2017–2024 (USD Million)
Table 71 Europe: Protein Engineering Market for Academic Research Institutes, By Country, 2017–2024 (USD Million)
Table 72 APAC: Market for Academic Research Institutes, By Country, 2017–2024 (USD Million)
Table 73 Market, By Region, 2017–2024 (USD Million)
Table 74 North America: Market, By Country, 2017–2024 (USD Million)
Table 75 North America: Market, By Product & Service, 2017–2024 (USD Million)
Table 76 North America: Market, By Technology, 2017–2024 (USD Million)
Table 77 North America: Market, By End User, 2017–2024 (USD Million)
Table 78 North America: Market, By Protein Type, 2017–2024 (USD Million)
Table 79 US: Market, By Product & Service, 2017–2024 (USD Million)
Table 80 US: Market, By Technology, 2017–2024 (USD Million)
Table 81 US: Market, By End User, 2017–2024 (USD Million)
Table 82 US: Market, By Protein Type, 2017–2024 (USD Million)
Table 83 Canada: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 84 Canada: Market, By Technology, 2017–2024 (USD Million)
Table 85 Canada: Market, By End User, 2017–2024 (USD Million)
Table 86 Canada: Market, By Protein Type, 2017–2024 (USD Million)
Table 87 Europe: Market, By Country, 2017–2024 (USD Million)
Table 88 Europe: Market, By Product & Service, 2017–2024 (USD Million)
Table 89 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 90 Europe: Market, By End User, 2017–2024 (USD Million)
Table 91 Europe: Market, By Protein Type, 2017–2024 (USD Million)
Table 92 Germany: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 93 Germany: Market, By Technology, 2017–2024 (USD Million)
Table 94 Germany: Market, By End User, 2017–2024 (USD Million)
Table 95 Germany: Market, By Protein Type, 2017–2024 (USD Million)
Table 96 UK: Market, By Product & Service, 2017–2024 (USD Million)
Table 97 UK: Market, By Technology, 2017–2024 (USD Million)
Table 98 UK: Market, By End User, 2017–2024 (USD Million)
Table 99 UK: Market, By Protein Type, 2017–2024 (USD Million)
Table 100 France: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 101 France: Market, By Technology, 2017–2024 (USD Million)
Table 102 France: Market, By End User, 2017–2024 (USD Million)
Table 103 France: Market, By Protein Type, 2017–2024 (USD Million)
Table 104 RoE: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 105 RoE: Market, By Technology, 2017–2024 (USD Million)
Table 106 RoE: Market, By End User, 2017–2024 (USD Million)
Table 107 RoE: Market, By Protein Type, 2017–2024 (USD Million)
Table 108 APAC: Market, By Country, 2017–2024 (USD Million)
Table 109 APAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 110 APAC: Market, By Technology, 2017–2024 (USD Million)
Table 111 APAC: Market, By End User, 2017–2024 (USD Million)
Table 112 APAC: Market, By Protein Type, 2017–2024 (USD Million)
Table 113 Japan: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 114 Japan: Market, By Technology, 2017–2024 (USD Million)
Table 115 Japan: Market, By End User, 2017–2024 (USD Million)
Table 116 Japan: Market, By Protein Type, 2017–2024 (USD Million)
Table 117 China: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 118 China: Market, By Technology, 2017–2024 (USD Million)
Table 119 China: Market, By End User, 2017–2024 (USD Million)
Table 120 China: Market, By Protein Type, 2017–2024 (USD Million)
Table 121 India: Market, By Product & Service, 2017–2024 (USD Million)
Table 122 India: Market, By Technology, 2017–2024 (USD Million)
Table 123 India: Protein Engineering Market, By End User, 2017–2024 (USD Million)
Table 124 India: Market, By Protein Type, 2017–2024 (USD Million)
Table 125 RoAPAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 126 RoAPAC: Market, By Technology, 2017–2024 (USD Million)
Table 127 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 128 RoAPAC: Market, By Protein Type, 2017–2024 (USD Million)
Table 129 RoW: Protein Engineering Market, By Product & Service, 2017–2024 (USD Million)
Table 130 RoW: Market, By Technology, 2017–2024 (USD Million)
Table 131 RoW: Market, By End User, 2017–2024 (USD Million)
Table 132 RoW: Market, By Protein Type, 2017–2024 (USD Million)

List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Protein Engineering Market
Figure 5 Market Data Triangulation Methodology
Figure 6 Market, By Product & Service, 2019 Vs. 2024 (USD Million)
Figure 7 Market, By Protein Type, 2019 Vs. 2024
Figure 8 Market Share, By Technology, 2018
Figure 9 Geographical Snapshot of the Market
Figure 10 Increasing Investments in Synthetic Biology to Drive Market Growth
Figure 11 Instruments Held the Largest Share of the Protein Engineering Market in the Asia Pacific
Figure 12 Biopharmaceutical Companies Dominated the Market in 2018
Figure 13 APAC to Witness the Highest Growth in the Market During the Forecast Period
Figure 14 Market: Drivers, Restraints, and Opportunities
Figure 15 Market: Geographic Growth Opportunities
Figure 16 North America: Market Snapshot
Figure 17 Asia Pacific: Market Snapshot
Figure 18 Rank of Companies in the Protein Engineering Market, 2018
Figure 19 Vendor Comparison Matrix: Market (2018)
Figure 20 Company Snapshot: Thermo Fisher Scientific, Inc. (2018)
Figure 21 Company Snapshot: Danaher Corporation (2018)
Figure 22 Company Snapshot: Agilent Technologies, Inc. (2019)
Figure 23 Company Snapshot: Bio-Rad Laboratories, Inc. (2018)
Figure 24 Company Snapshot: Bruker Corporation (2018)
Figure 25 Company Snapshot: Genscript Biotech Corporation (2018)
Figure 26 Company Snapshot: Codexis, Inc. (2018)
Figure 27 Company Snapshot: Waters Corporation (2018)
Figure 28 Company Snapshot: Merck KGaA (2018)
Figure 29 Company Snapshot: Perkinelmer, Inc. (2018)
Figure 30 Company Snapshot: GE Healthcare (2018)
Figure 31 Company Snapshot: Abzena, Ltd. (2018)
Figure 32 Company Snapshot: Takara Bio, Inc. (2019)

★調査レポート[世界のタンパク質工学市場:技術別(合理的設計、不合理な設計)、製品&サービス別(機器、消耗品)、タンパク質種類別(モノクローナル抗体、インスリン)、エンドユーザー別(アカデミックインスティテュート、バイオ医薬品、CRO)] (コード:BT 7517)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のタンパク質工学市場:技術別(合理的設計、不合理な設計)、製品&サービス別(機器、消耗品)、タンパク質種類別(モノクローナル抗体、インスリン)、エンドユーザー別(アカデミックインスティテュート、バイオ医薬品、CRO)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆